Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Optinose Inc (OPTN)

Optinose Inc (OPTN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
OptiNose: Q1 Earnings Snapshot

OptiNose: Q1 Earnings Snapshot

OPTN : 9.60 (-1.13%)
OptiNose: Q4 Earnings Snapshot

OptiNose: Q4 Earnings Snapshot

OPTN : 9.60 (-1.13%)
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights

OPTN : 9.60 (-1.13%)
Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight

Paratek will acquire Optinose's outstanding shares for $9 apiece in cash, representing a 50% premium to the stock’s closing trading price of $6 on March 19, and up to $5 per share in contingent value...

VXF : 200.14 (-2.00%)
VTI : 326.43 (-1.04%)
OPTN : 9.60 (-1.13%)
Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call

OPTN : 9.60 (-1.13%)
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results

OPTN : 9.60 (-1.13%)
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million

OPTN : 9.60 (-1.13%)
Optinose Announces 1-for-15 Reverse Stock Split

OPTN : 9.60 (-1.13%)
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference

OPTN : 9.60 (-1.13%)
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results

OPTN : 9.60 (-1.13%)

Barchart Exclusives

Unusual Options Activity Shows 71,000 Calls Hit the Tape for Applied Digital Stock – How You Should Play APLD Here
A massive burst of call activity has pushed Applied Digital into the spotlight, drawing traders toward a high-beta name already hit hard in the recent pullback. With clear price levels, moderate volatility, and a possible macro catalyst, APLD is shaping up as a stock to watch into the end of November. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar